ValuEngine downgraded shares of Medical Properties Trust, Inc. (NYSE:MPW) from a buy rating to a hold rating in a research report sent to investors on Friday morning.

A number of other equities analysts also recently issued reports on MPW. Jefferies Group LLC restated a buy rating and issued a $15.00 price target on shares of Medical Properties Trust in a research note on Tuesday, August 29th. Zacks Investment Research downgraded Medical Properties Trust from a buy rating to a hold rating in a research note on Wednesday, August 2nd. Stifel Nicolaus restated a hold rating and issued a $13.00 price target on shares of Medical Properties Trust in a research note on Friday, July 28th. BidaskClub upgraded Medical Properties Trust from a sell rating to a hold rating in a research note on Monday, July 24th. Finally, JMP Securities upgraded Medical Properties Trust from a market perform rating to an outperform rating and set a $14.00 price target on the stock in a research note on Monday, July 17th. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company’s stock. Medical Properties Trust has an average rating of Hold and a consensus price target of $14.10.

Shares of Medical Properties Trust (NYSE MPW) opened at 13.17 on Friday. The company has a market capitalization of $4.61 billion, a price-to-earnings ratio of 16.10 and a beta of 0.88. The firm has a 50 day moving average price of $12.82 and a 200 day moving average price of $13.03. Medical Properties Trust has a 52 week low of $11.54 and a 52 week high of $15.57.

Medical Properties Trust (NYSE:MPW) last issued its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.32 EPS for the quarter, meeting the consensus estimate of $0.32. The business had revenue of $166.80 million for the quarter, compared to the consensus estimate of $163.08 million. Medical Properties Trust had a return on equity of 7.54% and a net margin of 42.25%. The company’s revenue was up 32.1% compared to the same quarter last year. During the same period last year, the business posted $0.32 EPS. Equities analysts forecast that Medical Properties Trust will post $0.86 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This piece was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/04/medical-properties-trust-inc-mpw-downgraded-by-valuengine.html.

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, September 14th will be issued a $0.24 dividend. The ex-dividend date of this dividend is Wednesday, September 13th. This represents a $0.96 dividend on an annualized basis and a yield of 7.29%. Medical Properties Trust’s dividend payout ratio is currently 115.66%.

In related news, CFO R Steven Hamner sold 85,000 shares of the firm’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total value of $1,135,600.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.00% of the stock is currently owned by company insiders.

Institutional investors have recently made changes to their positions in the stock. IFP Advisors Inc raised its holdings in Medical Properties Trust by 15.1% in the 1st quarter. IFP Advisors Inc now owns 9,009 shares of the real estate investment trust’s stock worth $116,000 after purchasing an additional 1,182 shares during the period. Blair William & Co. IL bought a new position in Medical Properties Trust in the 2nd quarter worth $132,000. Neuburgh Advisers LLC raised its holdings in Medical Properties Trust by 6.2% in the 1st quarter. Neuburgh Advisers LLC now owns 10,582 shares of the real estate investment trust’s stock worth $136,000 after purchasing an additional 616 shares during the period. Janus Henderson Group PLC bought a new position in Medical Properties Trust in the 2nd quarter worth $136,000. Finally, Cetera Investment Advisers bought a new position in Medical Properties Trust in the 2nd quarter worth $141,000. 85.55% of the stock is currently owned by institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Stock Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related stocks with our FREE daily email newsletter.